Jobs / United States / Pfizer INC
Associate Research Fellow
Pfizer INC · 🇺🇸 United States - Massachusetts - Cambridge
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles1 certified filing for “CLINICAL STATISTICIAN, ASSOCIATE DIRECTOR” (Data Scientists) in MA: $183k–$183k, median $183k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
ROLE SUMMARY: The key strategic focus within the Internal Medicine Research Unit (IMRU) is identifying novel therapies to prevent or treat metabolic diseases such as obesity and cardiovascular disease. Our goal is to build a world-class research team of dedicated scientists committed to developing a deep mechanistic understanding of the metabolic pathways underlying disease pathogenesis. As a senior scientific leader and member of the obesity discovery biology team, this individual will play a significant role in shaping the scientific direction for the obesity therapeutic area and influencing broader IMRU research strategy and portfolio priorities. The individual will help create and drive discovery research strategy across multiple programs, including target ideation, validation, translational biomarker strategy, hypothesis testing, and early clinical development within the IMRU obesity portfolio. The successful candidate will lead through both direct team leadership and influence across multidisciplinary partners, helping align scientific decisions across discovery biology, translational sciences, clinical, computational, and external collaborators. The individual will identify emerging therapeutic opportunities, advance portfolio programs with scientific rigor and urgency, and represent research strategies to internal leadership and the external scientific community. Knowledge and experience in the study of metabolic pathways are essential, and familiarity with the pathophysiology of dysmetabolic states would be advantageous. Strong self-motivation, excellent communication and interpersonal skills, and the ability to lead, mentor, and build scientific capability in a highly collaborative environment are essential. ROLE RESPONSIBILITIES: • Shape and influence the scientific direction for discovery research programs aligned with IMRU therapeutic area and portfolio strategy. • Apply creative thinking and scientific expertise to formulate strategies that identify, prioritize, and validate therapeutic targets in key areas of interest to the Internal Medicine Research Unit. • Maintain awareness of cutting-edge scientific and technical developments in preclinical-to-clinical translation and apply these insights to advance portfolio programs and identify emerging opportunities. • Guide research priorities across multiple programs by integrating mechanistic biology, translational feasibility, biomarker strategy, and portfolio impact. • Conceptualize, design, and oversee rigorous in vivo, ex vivo, and in vitro studies, including experimental design, data collection, interpretation, and presentation. • Quantify and translate experimental results to advance understanding of how metabolic pathways and complex physiological systems are altered by disease and respond to therapeutic intervention. • Lead a research team of lab heads and scientists, providing supervision, coaching, and mentorship to develop skills essential to rigorous scientific research and drug discovery execution. • Lead through influence across multidisciplinary teams and key stakeholders, driving scientific alignment and decision-making where accountability extends beyond direct reporting lines. • Build and facilitate strategic collaborations with partners in the academic scientific community, the broader Pfizer network, and external experts to strengthen scientific insight and portfolio impact. • Establish external scientific leadership through peer-reviewed publications, scientific presentations, conference engagement, and thought leadership in relevant areas of metabolic disease biology. • Present and represent research programs, portfolio recommendations, and scientific strategy to Pfizer leadership and governance forums. • Ensure that all research and